Our analysis yielded thousands of data points and unearthed two critically important trends that we think are widely misunderstood or unknown by the VC ecosystem, the limited partners in the asset class, and the media that covers it.
FORBES: Life Sciences: The Rodney Dangerfield of Venture Capital